Notably, MYB transcription factors contribute significantly to chemotherapy resistance either as overexpressed oncogenes or as downregulated tumor suppressors, which mirrors the Janus-like character of MYB proteins in cancer progression and resistance formation. This evidence concerns the gene MYB and cancer.